title: Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.
abstract: Central dopaminergic and noradrenergic systems play essential roles in controlling several forebrain functions. Consequently, perturbations of these neurotransmissions may contribute to the pathophysiology of neuropsychiatric disorders. For many years, there was a focus on the serotonin (5-HT) system because of the efficacy of selective serotonin reuptake inhibitors (SSRIs), the most prescribed antidepressants in the treatment of major depressive disorder (MDD). Given the interconnectivity within the monoaminergic network, any action on one system may reverberate in the other systems. Analysis of this network and its dysfunctions suggests that drugs with selective or multiple modes of action on dopamine (DA) and norepinephrine (NE) may have robust therapeutic effects. This review focuses on NE-DA interactions as demonstrated in electrophysiological and neurochemical studies, as well as on the mechanisms of action of agents with either selective or dual actions on DA and NE. Understanding the mode of action of drugs targeting these catecholaminergic neurotransmitters can improve their utilization in monotherapy and in combination with other compounds particularly the SSRIs. The elucidation of such relationships can help design new treatment strategies for MDD, especially treatment-resistant depression.
authors.affiliation: University of Ottawa Institute of Mental Health Research, Ontario, Canada. mostafa.elmansari@rohcg.on.ca <mostafa.elmansari@rohcg.on.ca>
authors.forename: Mostafa
authors.initials: M
authors.lastname: El Mansari
authors.forename: Bruno P
authors.initials: BP
authors.lastname: Guiard
authors.forename: Olga
authors.initials: O
authors.lastname: Chernoloz
authors.forename: Ramez
authors.initials: R
authors.lastname: Ghanbari
authors.forename: Noam
authors.initials: N
authors.lastname: Katz
authors.forename: Pierre
authors.initials: P
authors.lastname: Blier
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002490:Central Nervous System / Q000378:metabolism* / Q000473:pathology; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D008954:Models, Biological; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism*
chemical_list: D000928:Antidepressive Agents; D004298:Dopamine; D009638:Norepinephrine
references.citation: Arch Gen Psychiatry. 1965 Dec;13(6):483-94
references.pmid: 5320621
references.citation: Neurochem Int. 1992 Mar;20 Suppl:231S-235S
references.pmid: 1365432
references.citation: J Clin Psychiatry. 2006;67 Suppl 4:22-6
references.pmid: 16683859
references.citation: Depress Anxiety. 2000;11(2):58-65
references.pmid: 10812530
references.citation: Neuropharmacology. 2008 Dec;55(7):1191-8
references.pmid: 18708076
references.citation: Int Clin Psychopharmacol. 1997 Jul;12 Suppl 3:S7-14
references.pmid: 9347387
references.citation: Psychopharmacology (Berl). 2002 Aug;163(1):102-5
references.pmid: 12185406
references.citation: Brain Res. 1975 Jul 11;92(2):291-306
references.pmid: 1174954
references.citation: J Clin Psychiatry. 2010 Feb;71(2):163-74
references.pmid: 20122366
references.citation: J Clin Psychiatry. 2005 Oct;66(10):1289-97
references.pmid: 16259543
references.citation: Eur J Pharmacol. 1991 Jul 23;200(1):65-72
references.pmid: 1685123
references.citation: Neuropharmacology. 2006 May;50(6):755-60
references.pmid: 16427661
references.citation: Eur J Neurosci. 2000 Mar;12(3):1079-95
references.pmid: 10762339
references.citation: Biol Psychiatry. 2007 Mar 1;61(5):671-8
references.pmid: 16934772
references.citation: J Neurochem. 1990 Sep;55(3):1067-70
references.pmid: 2117046
references.citation: Psychopharmacology (Berl). 1996 Mar;124(1-2):57-73
references.pmid: 8935801
references.citation: Eur J Pharmacol. 1993 Mar 16;233(1):79-84
references.pmid: 8097162
references.citation: J Psychiatr Res. 2009 Jan;43(3):205-14
references.pmid: 18586273
references.citation: Psychopharmacology (Berl). 2009 Oct;206(2):335-44
references.pmid: 19641901
references.citation: Pharmacopsychiatry. 2001 Jul;34(4):137-41
references.pmid: 11518474
references.citation: Int J Neuropsychopharmacol. 2008 Aug;11(5):625-39
references.pmid: 18205979
references.citation: Life Sci. 1984 Mar 19;34(12):1161-70
references.pmid: 6708722
references.citation: J Pharmacol Exp Ther. 1987 May;241(2):642-9
references.pmid: 3033221
references.citation: J Neurosci. 2002 Jan 15;22(2):389-95
references.pmid: 11784783
references.citation: J Neurochem. 1998 Jul;71(1):274-80
references.pmid: 9648875
references.citation: Annu Rev Neurosci. 2009;32:267-87
references.pmid: 19555290
references.citation: Am J Psychiatry. 2005 Jul;162(7):1351-60
references.pmid: 15994719
references.citation: Psychopharmacology (Berl). 2001 Oct;158(1):1-6
references.pmid: 11685378
references.citation: J Neurosci Res. 2008 May 15;86(7):1647-58
references.pmid: 18189323
references.citation: Biol Psychiatry. 2006 Nov 15;60(10):1111-20
references.pmid: 16806100
references.citation: Neuropsychopharmacology. 2003 Feb;28(2):413-20
references.pmid: 12589396
references.citation: Prog Brain Res. 1990;85:325-35; discussion 335-6
references.pmid: 2094903
references.citation: Neuroscience. 1998 Jun;84(4):1085-96
references.pmid: 9578397
references.citation: Brain Res. 1984 Feb 27;294(1):161-5
references.pmid: 6697233
references.citation: J Comp Neurol. 1994 Jun 1;344(1):121-36
references.pmid: 7914895
references.citation: Am J Psychiatry. 2010 Mar;167(3):281-8
references.pmid: 20008946
references.citation: J Pharmacol Exp Ther. 1995 Oct;275(1):412-21
references.pmid: 7562579
references.citation: Curr Neuropharmacol. 2006 Apr;4(2):115-25
references.pmid: 18615131
references.citation: Eur J Pharmacol. 1977 Aug 15;44(4):375-85
references.pmid: 330174
references.citation: Psychopharmacology (Berl). 2001 Apr;155(1):52-7
references.pmid: 11374336
references.citation: CNS Drugs. 2009;23 Suppl 1:33-41
references.pmid: 19621976
references.citation: J Pharmacol Exp Ther. 1994 Dec;271(3):1216-22
references.pmid: 7996429
references.citation: Neuropsychopharmacology. 2005 Apr;30(4):775-85
references.pmid: 15688090
references.citation: Neuropsychopharmacology. 2008 Sep;33(10):2303-12
references.pmid: 18059438
references.citation: J Pharmacol Exp Ther. 2007 Jan;320(1):376-85
references.pmid: 17005915
references.citation: Nat Rev Neurosci. 2009 Jun;10(6):410-22
references.pmid: 19455173
references.citation: Neuropsychopharmacology. 2001 Dec;25(6):845-57
references.pmid: 11750178
references.citation: J Affect Disord. 2005 Dec;89(1-3):115-23
references.pmid: 16213028
references.citation: N Engl J Med. 2006 Mar 23;354(12):1243-52
references.pmid: 16554526
references.citation: Depress Anxiety. 2006;23(3):178-81
references.pmid: 16528701
references.citation: Synapse. 1990;6(1):106-12
references.pmid: 1697988
references.citation: Am J Psychiatry. 1965 Nov;122(5):509-22
references.pmid: 5319766
references.citation: Neuropharmacology. 1986 Sep;25(9):1003-8
references.pmid: 3774122
references.citation: Arch Gen Psychiatry. 2007 Mar;64(3):327-37
references.pmid: 17339521
references.citation: J Biol Chem. 1994 Mar 11;269(10):7124-30
references.pmid: 8125921
references.citation: J Clin Psychiatry. 1984 Apr;45(4 Pt 2):56-9
references.pmid: 6370976
references.citation: J Comp Neurol. 2000 May 1;420(2):211-32
references.pmid: 10753308
references.citation: Synapse. 2000 Feb;35(2):111-9
references.pmid: 10611636
references.citation: Cereb Cortex. 2007 Sep;17 Suppl 1:i6-15
references.pmid: 17434919
references.citation: J Clin Psychiatry. 1984 Apr;45(4 Pt 2):78-84
references.pmid: 6370982
references.citation: Int J Neuropsychopharmacol. 2005 Sep;8(3):329-39
references.pmid: 15737250
references.citation: J Affect Disord. 1998 Dec;51(3):255-66
references.pmid: 10333981
references.citation: J Comp Neurol. 1979 Sep 1;187(1):117-43
references.pmid: 489776
references.citation: Int J Neuropsychopharmacol. 2011 Mar;14(2):211-23
references.pmid: 20149268
references.citation: J Neural Transm. 1987;70(3-4):183-91
references.pmid: 2445911
references.citation: Curr Drug Targets. 2009 Nov;10(11):1069-84
references.pmid: 19702555
references.citation: Neuropsychopharmacology. 1994 Oct;11(2):133-41
references.pmid: 7840865
references.citation: J Neurochem. 2001 May;77(3):762-75
references.pmid: 11331405
references.citation: Eur J Pharmacol. 1978 Nov 1;52(1):27-36
references.pmid: 214312
references.citation: J Pharmacol Exp Ther. 2001 May;297(2):540-6
references.pmid: 11303041
references.citation: Neuropsychopharmacology. 1992 Aug;7(1):7-14
references.pmid: 1381923
references.citation: Psychopharmacology (Berl). 2005 Aug;181(1):126-33
references.pmid: 15719213
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1977 Mar;297(1):1-7
references.pmid: 193046
references.citation: Am J Psychiatry. 1999 May;156(5):798
references.pmid: 10327923
references.citation: Brain Res Bull. 1982 Jul-Dec;9(1-6):321-53
references.pmid: 6816390
references.citation: Brain Res. 1991 Nov 15;564(2):203-19
references.pmid: 1839781
references.citation: Neuropsychopharmacology. 2009 Feb;34(3):651-61
references.pmid: 18688211
references.citation: J Neurosci. 2009 Mar 18;29(11):3613-26
references.pmid: 19295165
references.citation: Neuroscience. 1987 Jan;20(1):117-55
references.pmid: 2882443
references.citation: Arch Gen Psychiatry. 1996 Feb;53(2):117-28
references.pmid: 8629887
references.citation: Synapse. 2004 Jun 15;52(4):233-44
references.pmid: 15103690
references.citation: J Clin Psychopharmacol. 2003 Jun;23(3):233-9
references.pmid: 12826985
references.citation: J Neurochem. 1994 Jul;63(1):195-200
references.pmid: 8207428
references.citation: Biol Psychiatry. 2006 Feb 1;59(3):203-10
references.pmid: 16165100
references.citation: J Clin Psychiatry. 2006 Jan;67(1):148-59
references.pmid: 16426101
references.citation: Biol Psychiatry. 2004 Jun 1;55(11):1103-9
references.pmid: 15158430
references.citation: Eur J Neurosci. 2001 Jun;13(11):2077-87
references.pmid: 11422448
references.citation: J Clin Psychopharmacol. 2000 Apr;20(2):274-5
references.pmid: 10770475
references.citation: Neuropharmacology. 2002 Feb;42(2):181-90
references.pmid: 11804614
references.citation: J Clin Psychiatry. 2005;66 Suppl 8:30-40
references.pmid: 16336034
references.citation: J Clin Psychiatry. 1995 Sep;56(9):395-401
references.pmid: 7665537
references.citation: Brain Res. 1977 May 20;127(1):1-21
references.pmid: 67877
references.citation: CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207
references.pmid: 17227286
references.citation: Psychopharmacology (Berl). 1994 Jun;115(1-2):285-8
references.pmid: 7862908
references.citation: J Pharmacol Exp Ther. 1994 Mar;268(3):1297-303
references.pmid: 8138943
references.citation: Mol Pharmacol. 2008 Nov;74(5):1463-75
references.pmid: 18703671
references.citation: Adv Biochem Psychopharmacol. 1977;16:433-8
references.pmid: 883551
references.citation: Neuropharmacology. 1983 Nov;22(11):1257-67
references.pmid: 6320035
references.citation: Psychopharmacology (Berl). 1997 Dec;134(3):309-17
references.pmid: 9438681
references.citation: J Biol Chem. 1994 Jun 10;269(23):15985-8
references.pmid: 8206893
references.citation: Trends Pharmacol Sci. 1994 Jul;15(7):220-6
references.pmid: 7940983
references.citation: Neuron. 1995 Mar;14(3):477-85
references.pmid: 7695894
references.citation: Cell. 2007 Apr 20;129(2):397-410
references.pmid: 17448997
references.citation: J Neurosci. 1996 Mar 1;16(5):1922-35
references.pmid: 8774459
references.citation: J Psychopharmacol. 2010 Aug;24(8):1223-35
references.pmid: 19939862
references.citation: J Clin Psychiatry. 2008 Feb;69(2):246-58
references.pmid: 18363453
references.citation: Eur J Pharmacol. 2000 Apr 21;395(1):31-6
references.pmid: 10781670
references.citation: Neuropharmacology. 1980 Apr;19(4):355-63
references.pmid: 6104308
references.citation: Annu Rev Neurosci. 2009;32:57-74
references.pmid: 19400725
references.citation: Sleep. 2003 Nov 1;26(7):801-6
references.pmid: 14655911
references.citation: Psychopharmacology (Berl). 2011 Sep;217(1):61-73
references.pmid: 21445565
references.citation: Neuropharmacology. 1989 Dec;28(12):1383-8
references.pmid: 2533329
references.citation: Eur J Pharmacol. 2004 Nov 3;504(1-2):61-4
references.pmid: 15507222
references.citation: Biol Psychiatry. 1992 Jul 1;32(1):1-17
references.pmid: 1391289
references.citation: Depress Anxiety. 2004;20(3):131-8
references.pmid: 15549689
references.citation: CNS Spectr. 2009 Apr;14(4):197-206
references.pmid: 19407731
references.citation: Crit Rev Neurobiol. 2004;16(1-2):121-8
references.pmid: 15581407
references.citation: Ann Intern Med. 2007 Nov 6;147(9):593-602
references.pmid: 17975181
references.citation: J Neurophysiol. 2006 Dec;96(6):3006-15
references.pmid: 17005616
references.citation: Psychopharmacology (Berl). 2007 Sep;194(1):63-72
references.pmid: 17530476
references.citation: Eur J Pharmacol. 1989 Jun 8;165(1):11-8
references.pmid: 2569981
references.citation: Biol Psychiatry. 2003 Oct 15;54(8):800-5
references.pmid: 14550679
references.citation: J Neurosci. 1998 Feb 15;18(4):1613-21
references.pmid: 9454866
references.citation: J Pharmacol Exp Ther. 1984 Nov;231(2):275-80
references.pmid: 6491980
references.citation: J Neural Transm. 1979;44(1-2):77-86
references.pmid: 220380
references.citation: J Pharmacol Exp Ther. 2002 Sep;302(3):983-91
references.pmid: 12183655
references.citation: J Pharmacol Exp Ther. 1986 Jun;237(3):987-94
references.pmid: 2423685
references.citation: Behav Brain Funct. 2005 Apr 22;1(1):2
references.pmid: 15916700
references.citation: J Comp Neurol. 1985 Jan 8;231(2):190-208
references.pmid: 2981906
references.citation: Bipolar Disord. 2002 Oct;4(5):307-14
references.pmid: 12479663
references.citation: J Comp Neurol. 2005 Sep 26;490(3):270-94
references.pmid: 16082674
references.citation: Brain Res. 1998 Jan 1;779(1-2):58-74
references.pmid: 9473588
references.citation: J Appl Physiol (1985). 2003 Aug;95(2):652-6
references.pmid: 12692144
references.citation: Science. 1979 Aug 31;205(4409):929-32
references.pmid: 112679
references.citation: Neuropsychopharmacology. 2002 Aug;27(2):237-47
references.pmid: 12093597
references.citation: Ann Clin Psychiatry. 2000 Sep;12(3):137-40
references.pmid: 10984002
references.citation: Neuropsychopharmacology. 2003 Jun;28(6):1140-9
references.pmid: 12700697
references.citation: Eur J Pharmacol. 2001 Apr 27;418(3):177-86
references.pmid: 11343687
references.citation: Brain Res Brain Res Rev. 1997 Apr;23(3):145-95
references.pmid: 9164669
references.citation: Nat Neurosci. 2007 Mar;10(3):376-84
references.pmid: 17277774
references.citation: J Clin Psychopharmacol. 2006 Dec;26(6):600-9
references.pmid: 17110817